sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at MedInvest Biotech & Pharma Investor Conference
Jaguar Health, Inc. (NASDAQ:JAGX) announced that CEO Lisa Conte will present at the MedInvest Biotech & Pharma Investor Conference on September 19, 2024. The event will take place in New York City from September 18-19. Conte’s presentation is scheduled for 9:55 AM to 10:10 AM Eastern.
Jaguar Health is a commercial-stage pharmaceuticals company focused on developing proprietary medicines from rainforest plants. Its subsidiary, Napo Pharmaceuticals, concentrates on human prescription drugs for neglected gastrointestinal symptoms. The company’s FDA-approved drug, Mytesi®, provides relief for noninfectious diarrhea in HIV/AIDS patients on antiretroviral therapy.
Additionally, Jaguar's Napo Therapeutics aims to expand access to crofelemer in Europe, targeting orphan and rare diseases. Magdalena Biosciences, a joint venture with Filament Health Corp., focuses on mental health treatments derived from plants.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.